Guodong Cao

机构：Anhui Medical University, First Affiliated Hospital of Anhui Medical University · ORCID：0000-0002-4796-6430

发表论文 62 篇 · 总被引 1938 次 · h-index 22

代表论文

• Tumor-Derived Lactate Creates a Favorable Niche for Tumor via Supplying Energy Source for Tumor and Modulating the Tumor Microenvironment (2022 · Frontiers in Cell and Developmental Biology · 被引 80)
• Hyperglycemia induces miR-26-5p down-regulation to overexpress PFKFB3 and accelerate epithelial–mesenchymal transition in gastric cancer (2022 · Bioengineered · 被引 29)
• PTPRC promoted CD8+ T cell mediated tumor immunity and drug sensitivity in breast cancer: based on pan-cancer analysis and artificial intelligence modeling of immunogenic cell death-based drug sensitivity stratification (2023 · Frontiers in Immunology · 被引 20)
• Mesothelin targeted nano-system enhanced chemodynamic therapy and tirapazamine chemotherapy via lactate depletion (2023 · Nano Research · 被引 20)
• Tumor suppressive function of IGF2BP1 in gastric cancer through decreasing MYC (2023 · Cancer Science · 被引 15)
• Development and Validation of a Pyroptosis-Related Signature for Predicting Prognosis in Hepatocellular Carcinoma (2022 · Frontiers in Genetics · 被引 15)